MedPath

Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

Not Applicable
Conditions
Atrial Fibrillation
Registration Number
NCT00844584
Lead Sponsor
Xijing Hospital
Brief Summary

Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years.

Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room.

Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Any patients with atrial fibrillation
Exclusion Criteria
  • Patients with hemostasis defects
  • patients can not endure general anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Electrocardiography2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Cardiovascular Surgery, Xijing Hospital

🇨🇳

Xi'an, Shannxi, China

Institute of Cardiovascular Surgery, Xijing Hospital
🇨🇳Xi'an, Shannxi, China
Dinghua Yi, MD
Contact
86-29-84775307
yidinghua@yahoo.com.cn
Zhenxiao Jin, MD
Principal Investigator
Xuezeng Xu, MD
Sub Investigator
Shiqiang Yu, MD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath